Evaluation of Bystander Infection of Oncolytic Virus using a Medium Flow Integrated 3D In Vitro Microphysiological System
Open Access
- 11 December 2019
- journal article
- research article
- Published by Wiley in Advanced Biosystems
- Vol. 4 (2) , e1900143
Abstract
Replicable oncolytic viruses (OVs) induce tumor cell lysis and release viral progeny. The released progeny virions and cell debris can spread within surrounding tumor cells or blood vessels. These released molecules may also induce bystander damage in additional tumor cells through spreading within surrounding tumor cells or blood vessels. However, this effect has not been clearly demonstrated due to the difficulty of direct observation. Here, the bystander infection of OVs by vessel delivery and selective infection in 3D multicellular tumoroids (MCTs) in an in vitro microphysiological system (MPS) with integrated medium flow is demonstrated. This study uses replicable vesicular stomatitis virus (VSV)‐green fluorescence protein (GFP) to identify the location of infection in 3D MCTs. Using this MPS, the oncoselective infection by VSV‐GFP and the spreading by delivery of OVs through flow via block‐to‐block linkage of the primary infected MPS with uninfected 3D MCTs in an integrated MPS is observed. This MPS enables real‐time monitoring and various analysis for the bystander infection of OVs. It is expected that the 3D in vitro MPS can be suitable to investigate the oncoselective spreading and bystander infection of OVs.Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2019R1A2C2005244, NRF‐2019R1C1C1007468)
This publication has 25 references indexed in Scilit:
- Spheroid culture as a tool for creating 3D complex tissuesTrends in Biotechnology, 2013
- Systemic Delivery of Oncolytic Viruses: Hopes and HurdlesAdvances in Virology, 2012
- Oncolytic Virotherapy for Hematological MalignanciesAdvances in Virology, 2011
- Strategies to Enhance Viral Penetration of Solid TumorsHuman Gene Therapy, 2011
- Human Adenovirus Type 5 Induces Cell Lysis through Autophagy and Autophagy-Triggered Caspase ActivityJournal of Virology, 2011
- Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysisAdvanced Drug Delivery Reviews, 2009
- Spheroid-based drug screen: considerations and practical approachNature Protocols, 2009
- Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood FlowMolecular Therapy, 2007
- Oncolytic viruses in cancer therapyCancer Letters, 2007
- Replication and Cytopathic Effect of Oncolytic Vesicular Stomatitis Virus in Hypoxic Tumor Cells In Vitro and In VivoJournal of Virology, 2004